[Sleep disorders in chronic pain and generalized tendomyopathy]

Area of Science:

• Neuroscience
• Sleep Medicine
• Rheumatology

Background:

• Chronic pain syndromes frequently involve sleep disturbances.
• Fibromyalgia syndrome (FMS) is characterized by both chronic pain and sleep issues.
• Objective polysomnographic data on FMS sleep disturbances are lacking.

Purpose of the Study:

• To objectively characterize sleep disturbances in FMS patients using electroencephalography (EEG).
• To investigate the relationship between sleep alterations and pain intensity in FMS.
• To evaluate the efficacy of the 5-HT2-receptor antagonist ketanserine in managing FMS-related sleep and pain.

Main Methods:

• Sleep EEG recordings were performed on 13 FMS patients.
• A placebo-controlled study assessed the effects of ketanserine.
• Pain intensity and sleep continuity were primary outcome measures.

Main Results:

• Sleep alterations in FMS are primarily characterized by disturbed sleep continuity.
• Sleep disturbance severity correlates with perceived pain intensity.
• Ketanserine demonstrated potential benefits for sleep and pain in FMS patients.

Conclusions:

• Sleep continuity disturbance is a key objective finding in FMS, linked to pain.
• 5-HT2-receptor antagonists like ketanserine may offer a dual therapeutic strategy for FMS and associated sleep issues.
• Further research is warranted to validate ketanserine's efficacy and explore illness duration as a prognostic factor.